KDR and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, following an ELISA analysis, ART’s inhibitory effects on vascular endothelial growth factor expression (VEGF) receptor KDR/flk-1 in tumour cells in chronic myeloid leukaemia (K526 cells) were discovered.